SOM230 LAR With Bortezomib and Dexamethasone for Refractory or Relapsed Multiple Myeloma

Stopped Clinical trial being transferred to Columbia University with the Investigator.

Conditions

• Multiple Myeloma in Relapse
• Multiple Myeloma

Interventions

• DRUG: SOM230
• DRUG: Bortezomib
• DRUG: Dexamethasone

Sponsor

University of Pittsburgh

Collaborators

• [object Object]